Premium
The 2‐week wait and other initiatives to improve cancer diagnosis: Has it altered survival? The answer is unclear—the evidence is too weak
Author(s) -
Bankhead C.
Publication year - 2017
Publication title -
european journal of cancer care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.849
H-Index - 67
eISSN - 1365-2354
pISSN - 0961-5423
DOI - 10.1111/ecc.12712
Subject(s) - medicine , cancer survival , cancer , overall survival , stage (stratigraphy) , intensive care medicine , oncology , paleontology , biology
The UK is one of the lowest ranked high‐income countries for cancer survival. Later stage at diagnosis is a significant contributor to reduced survival. Several strategies have been introduced to reduce delays in an effort to diagnose cancer earlier. This commentary summarises the evidence and impact of these initiatives.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom